SummitTX Capital »

Structure Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.6M 95k 69.55

More positions owned by SummitTX Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Asml Holding N V N Y Registry Shs (ASML)
Eli Lilly & Co. (LLY)
MKS Instruments (MKSI)
Wal-Mart Stores (WMT)
Paypal Holdings (PYPL)
Applied Materials (AMAT)
Amazon (AMZN)
Anthem (ELV)
Costco Wholesale Corporation (COST)
UnitedHealth (UNH)
Meritage Homes Corporation (MTH)

View all positions for SummitTX Capital

Top funds holding Structure Therapeutics

venBio Select Advisor
Wellington Management Company
FMR
Henderson Group
Deep Track Capital
BVF
Baker Bros. Advisors
RA Capital Management
Principal Financial Group
Millennium Management
Casdin Capital
OrbiMed Advisors
Siren
TCG Crossover Management
Driehaus Capital Management

View all funds holding Structure Therapeutics